BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Oct. 7, 2005
View Archived Issues
GHRH JV-1-42 crosses blood-brain barrier, indicating possible use for malignant glioblastomas
Read More
Urigen receives IND clearance for phase IIb study of U-101
Read More
Bristol-Myers Squibb profiles recent events
Read More
Alimera and CDS begin phase III diabetic macular edema trial
Read More
pSivida to acquire Control Delivery Systems
Read More
PharmaMar's PM-02734 enters clinic
Read More
European orphan drug designation for Niprisan for sickle cell disease
Read More
Vertex refocuses pipeline priorities for 2006
Read More
Nidek to develop epinastine hydrochloride eye drops in Japan
Read More
Gentium private offering to fund pipeline development
Read More
Canadian clearance for phase II trial of Proxinium
Read More
Orphan drug status for ZymoGenetics' IL-21 for melanoma
Read More
NF-kappa B decoy oligo begins Japanese phase I study for atopic dermatitis
Read More
Remicade approved in E.U. for moderate to severe plaque psoriasis
Read More
FDA approves new indication for Aromasin
Read More
Data from nonhuman primate studies on SB-462795, an investigational drug for osteoporosis
Read More
Astellas Pharma scientists identify a novel glycogen phosphorylase inhibitor
Read More
New title added to the Drug R&D Backgrounders topic list - Rosacea
Read More
CP-744809 shows promise for treating diabetic complications
Read More
A novel XIAP inhibitor TPI-1540-14 sensitizes CLL cells to CD40-targeted therapy
Read More
CDP-323 improves clinical scores in EAE mice
Read More
Phase II data on the effects and safety of LymphoStat-B in SLE
Read More
A phase III study confirms the efficacy of lubiprostone in constipation
Read More
Update on the effects and safety of cilansetron in IBS-D
Read More
Clinical data support the use of entecavir in chronic hepatitis B
Read More
Evidence suggests the DP1 receptor may be a novel target for antiallergic therapies
Read More
Low-dose risperidone reported to improve behavior in children with autism
Read More
Recent patents cover novel agents for respiratory and other inflammatory disorders
Read More
Novel drugs for lipoprotein disorders, obesity etc. claimed in recent patents
Read More